azetirelin has been researched along with Ataxia in 2 studies
*Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwak, S; Matsui, K; Wada, K | 1 |
| Shimizu, M; Yamamoto, M | 1 |
2 other study(ies) available for azetirelin and Ataxia
| Article | Year |
|---|---|
Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice.
Topics: Animals; Ataxia; Azetidines; Dipeptides; Mice; Mice, Neurologic Mutants; Motor Activity; Thyrotropin-Releasing Hormone | 1994 |
Effect of YM-14673, a new thyrotropin releasing hormone analogue, on ataxic gait in cytosine arabinoside-treated mice.
Topics: Animals; Animals, Newborn; Ataxia; Azetidines; Azetines; Cytarabine; Dipeptides; Gait; Male; Mice; Mice, Inbred ICR; Motor Activity; Thyrotropin-Releasing Hormone | 1989 |